KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Co-Diagnostics (CODX) Assets Average (2017 - 2025)

Historic Assets Average for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $45.6 million.

  • Co-Diagnostics' Assets Average fell 4042.0% to $45.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.6 million, marking a year-over-year decrease of 4042.0%. This contributed to the annual value of $79.7 million for FY2024, which is 2705.33% down from last year.
  • Latest data reveals that Co-Diagnostics reported Assets Average of $45.6 million as of Q3 2025, which was down 4042.0% from $50.8 million recorded in Q2 2025.
  • Co-Diagnostics' 5-year Assets Average high stood at $166.0 million for Q2 2022, and its period low was $45.6 million during Q3 2025.
  • Moreover, its 5-year median value for Assets Average was $99.1 million (2021), whereas its average is $102.1 million.
  • Per our database at Business Quant, Co-Diagnostics' Assets Average surged by 57130.07% in 2021 and then crashed by 4042.0% in 2025.
  • Co-Diagnostics' Assets Average (Quarter) stood at $132.7 million in 2021, then grew by 2.09% to $135.5 million in 2022, then dropped by 24.7% to $102.0 million in 2023, then crashed by 33.15% to $68.2 million in 2024, then tumbled by 33.12% to $45.6 million in 2025.
  • Its Assets Average was $45.6 million in Q3 2025, compared to $50.8 million in Q2 2025 and $59.6 million in Q1 2025.